Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Extended Spectrum β-lactamase and Carbapenem-Resistant Gram-Negative Bacteria in Patients With Urinary Tract Infection and Urosepsis Admitted Through Emergency Departments in the United States

NCT03346603 is registered in ClinicalTrials.gov with Olive View-UCLA Education & Research Institute as lead sponsor.

NCT NCT03346603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03346603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Extended Spectrum β-lactamase and Carbapenem-Resistant Gram-Negative Bacteria in Patients With Urinary Tract Infection and Urosepsis Admitted Through Emergency Departments in the United States
Lead sponsor
Olive View-UCLA Education & Research Institute
Phase
Observational
Overall status
Completed
Start date
February 8, 2018
Completion date
December 31, 2020
Enrollment
801 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

urinary tract infections, urosepsis